Leadership Overview
Synokem Pharmaceuticals has 4 executives leading key functions including drug regulatory affairs, clinical development, and exports.
Driven by a commitment to global health, Synokem Pharmaceuticals aims to provide quality, affordable pharmaceutical products worldwide, fostering growth through strategic international partnerships and a strong focus on research and development.
Driven by a commitment to global health, Synokem Pharmaceuticals aims to provide quality, affordable pharmaceutical products worldwide, fostering growth through strategic international partnerships and a strong focus on research and development.
Leadership Roles at Synokem Pharmaceuticals
Aditya Kaushik - President, Drug Regulatory Affairs, Clinical Development
Aditya Kaushik, the President, Drug Regulatory Affairs, Clinical Development at Synokem Pharmaceuticals, directs the complex landscape of global drug approvals and clinical trial execution. Overseeing the strategic navigation of regulatory bodies across diverse international markets, Kaushik ensures Synokem Pharmaceuticals' products meet stringent compliance standards for market entry. This leadership role involves architecting robust clinical development pathways, from initial study design to final data analysis, directly supporting the company's vision of becoming a world-class manufacturer. By fostering collaboration between research teams and regulatory agencies, Aditya Kaushik drives the efficient progression of new pharmaceutical innovations from concept to commercialization, reinforcing the company's commitment to providing affordable, quality medicines. The President, Drug Regulatory Affairs, Clinical Development's focus on meticulous compliance and scientific rigor is paramount to expanding Synokem's global footprint and enhancing its market share through ethical marketing and exports.
Rajan Mahendru - President
Rajan Mahendru, the President at Synokem Pharmaceuticals, spearheads the overarching strategic direction and operational execution of the organization. This executive leadership position involves guiding Synokem Pharmaceuticals' mission to deliver affordable, high-quality pharmaceutical products across all societal segments. Mahendru's responsibilities encompass fostering a culture of continuous improvement and innovation, essential for achieving the company's goal of becoming a world-class manufacturer. By championing strategic alliances and collaborations, particularly within the international business sector, Rajan Mahendru actively works to enhance the company's market share and global reach. The President's oversight extends to ensuring operational efficiency and driving growth initiatives that align with Synokem's long-term objectives, solidifying its position in the competitive pharmaceutical landscape through ethical marketing and robust institutional supplies.
Pankaj Synokempharma - President - Exports
Pankaj Synokempharma, the President - Exports at Synokem Pharmaceuticals, drives the company's international market expansion and global sales strategy. This critical role focuses on identifying and capitalizing on opportunities within diverse overseas markets, directly contributing to Synokem Pharmaceuticals' objective of becoming a world-class manufacturer. Synokempharma oversees the development and implementation of export initiatives, ensuring compliance with international trade regulations and market-specific requirements. By cultivating strong relationships with global distributors and partners, the President - Exports facilitates the seamless delivery of affordable, quality pharmaceutical products to a wider customer base. Pankaj Synokempharma's leadership is instrumental in enhancing the company's global presence and achieving significant growth through strategic alliances and collaborations, reinforcing Synokem's commitment to ethical marketing and institutional supplies on an international scale.
Sandeep Soni - President
Sandeep Soni, the President at Synokem Pharmaceuticals, directs key operational facets and strategic initiatives that underpin the company's growth trajectory. This leadership role is central to Synokem Pharmaceuticals' commitment to providing accessible, high-quality pharmaceutical products, aligning with the vision of becoming a globally recognized manufacturer. Soni's focus includes optimizing contract manufacturing processes and enhancing the efficiency of ethical marketing and institutional supply chains. By fostering innovation and driving operational excellence, Sandeep Soni supports the company's ambition to significantly increase its market share through strategic international collaborations. The President's influence extends to championing research and development efforts, ensuring Synokem remains at the forefront of pharmaceutical advancements and solidifies its reputation for reliability and quality in both domestic and international arenas.
Explore Leadership Teams in Manufacturing
Telix Pharmaceuticals is a global, commercial-stage biopharmaceutical company headquartered in North Melbourne, Australia, founded in 2015 and publicly listed on the Australian Securities Exchange and Nasdaq under the ticker TLX. The company specializes in the development and commercialization of diagnostic and therapeutic radiopharmaceuticals, commonly referred to as theranostics, which use molecularly targeted radiation to both image and treat cancer. Telix's pipeline is focused on urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma), and bone marrow conditioning. Its lead commercial product, Illuccix, is an approved PSMA-PET/CT imaging agent for prostate cancer with regulatory clearance from the FDA, Australia's TGA, and Health Canada.
Company Leadership AG
Founded in 1850 and headquartered in Johannesburg, South Africa, Aspen Pharmacare Holdings Limited is a global specialty and branded pharmaceutical company headquartered in Durban, South Africa. Operating across Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia, Aspen focuses on sterile injectables (including anaesthetics, anticoagulants, antithrombotics, analgesics, and hormone replacement therapies), over-the-counter medicines, and prescription products for conditions such as hypothyroidism, autoimmune disease, pain, gout, and inflammatory disorders. The company also manufactures active pharmaceutical ingredients and finished dose forms, including steriles, oral solids, liquids, semi-solids, biologicals, and heparins, supplying both its own brands and third-party customers worldwide.
Company Leadership
TS
JW
American Regent, Inc, a Daiichi Sankyo Group Company, develops, manufactures, and supplies high quality sterile injectables for healthcare providers, clinics and hospitals across the United States and Canada. We have locations in New York, Ohio, and Pennsylvania and sales territories nationwide.
Company Leadership
JB
JO
Ajanta Pharma is an Indian multinational pharmaceutical company that develops, manufactures, and markets a broad range of branded and generic pharmaceutical products for both domestic and international markets. The company’s portfolio spans multiple therapeutic areas, including cardiology, dermatology, anti‑infectives, pain management, and ophthalmology, with products distributed through its own sales and marketing networks as well as through partnerships. Ajanta Pharma focuses on research, regulatory compliance, and quality manufacturing to support access to affordable medicines, while also expanding its presence in global markets across Asia, Africa, and other regions. The company’s operations encompass formulation development, compliance with international standards, and strategic market expansion to serve diverse healthcare needs.
Company Leadership SA
AK
RJ
PV
Frequently Asked Questions Regarding Synokem Pharmaceuticals Top Executives and Leadership Team
